nodes	percent_of_prediction	percent_of_DWPC	metapath
Lithium—GSK3B—embryo—polycystic ovary syndrome	0.0192	0.0609	CbGeAlD
Lithium—GRIA3—adrenal cortex—polycystic ovary syndrome	0.0182	0.0576	CbGeAlD
Lithium—IMPA1—female gonad—polycystic ovary syndrome	0.0144	0.0456	CbGeAlD
Lithium—IMPA2—endometrium—polycystic ovary syndrome	0.0143	0.0454	CbGeAlD
Lithium—GSK3A—adrenal cortex—polycystic ovary syndrome	0.0137	0.0434	CbGeAlD
Lithium—IMPA1—endocrine gland—polycystic ovary syndrome	0.0134	0.0424	CbGeAlD
Lithium—GRIA3—adrenal gland—polycystic ovary syndrome	0.0131	0.0416	CbGeAlD
Lithium—IMPA2—pituitary gland—polycystic ovary syndrome	0.013	0.0411	CbGeAlD
Lithium—GSK3B—uterus—polycystic ovary syndrome	0.013	0.041	CbGeAlD
Lithium—IMPA2—adipose tissue—polycystic ovary syndrome	0.0129	0.0409	CbGeAlD
Lithium—GSK3B—adipose tissue—polycystic ovary syndrome	0.0127	0.0401	CbGeAlD
Lithium—GSK3A—endometrium—polycystic ovary syndrome	0.0122	0.0387	CbGeAlD
Lithium—IMPA2—adrenal gland—polycystic ovary syndrome	0.0116	0.0367	CbGeAlD
Lithium—GSK3B—adrenal gland—polycystic ovary syndrome	0.0114	0.036	CbGeAlD
Lithium—GSK3A—uterus—polycystic ovary syndrome	0.0113	0.0357	CbGeAlD
Lithium—GSK3A—pituitary gland—polycystic ovary syndrome	0.0111	0.035	CbGeAlD
Lithium—GSK3A—adipose tissue—polycystic ovary syndrome	0.011	0.0349	CbGeAlD
Lithium—IMPA2—female gonad—polycystic ovary syndrome	0.0108	0.0342	CbGeAlD
Lithium—IMPA2—vagina—polycystic ovary syndrome	0.0107	0.034	CbGeAlD
Lithium—GSK3B—female gonad—polycystic ovary syndrome	0.0106	0.0336	CbGeAlD
Lithium—GSK3B—vagina—polycystic ovary syndrome	0.0105	0.0334	CbGeAlD
Lithium—GSK3A—adrenal gland—polycystic ovary syndrome	0.00988	0.0313	CbGeAlD
Lithium—GSK3B—endocrine gland—polycystic ovary syndrome	0.00986	0.0312	CbGeAlD
Lithium—GSK3A—female gonad—polycystic ovary syndrome	0.00922	0.0292	CbGeAlD
Lithium—GSK3A—vagina—polycystic ovary syndrome	0.00916	0.029	CbGeAlD
Lithium—GSK3A—endocrine gland—polycystic ovary syndrome	0.00857	0.0271	CbGeAlD
Lithium—Taste metallic—Metformin—polycystic ovary syndrome	0.00283	0.206	CcSEcCtD
Lithium—Chest discomfort—Metformin—polycystic ovary syndrome	0.00102	0.0741	CcSEcCtD
Lithium—Lethargy—Metformin—polycystic ovary syndrome	0.000666	0.0485	CcSEcCtD
Lithium—Dehydration—Metformin—polycystic ovary syndrome	0.000607	0.0442	CcSEcCtD
Lithium—Drowsiness—Metformin—polycystic ovary syndrome	0.000503	0.0367	CcSEcCtD
Lithium—Bradycardia—Metformin—polycystic ovary syndrome	0.00046	0.0335	CcSEcCtD
Lithium—Flatulence—Metformin—polycystic ovary syndrome	0.000387	0.0282	CcSEcCtD
Lithium—Dysgeusia—Metformin—polycystic ovary syndrome	0.000385	0.0281	CcSEcCtD
Lithium—Vision blurred—Metformin—polycystic ovary syndrome	0.00037	0.027	CcSEcCtD
Lithium—Tremor—Metformin—polycystic ovary syndrome	0.000368	0.0268	CcSEcCtD
Lithium—Syncope—Metformin—polycystic ovary syndrome	0.000352	0.0257	CcSEcCtD
Lithium—Loss of consciousness—Metformin—polycystic ovary syndrome	0.000345	0.0252	CcSEcCtD
Lithium—Discomfort—Metformin—polycystic ovary syndrome	0.000331	0.0241	CcSEcCtD
Lithium—Oedema—Metformin—polycystic ovary syndrome	0.000321	0.0234	CcSEcCtD
Lithium—Shock—Metformin—polycystic ovary syndrome	0.000315	0.023	CcSEcCtD
Lithium—Anorexia—Metformin—polycystic ovary syndrome	0.000306	0.0223	CcSEcCtD
Lithium—Hypotension—Metformin—polycystic ovary syndrome	0.0003	0.0218	CcSEcCtD
Lithium—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.000292	0.0213	CcSEcCtD
Lithium—Somnolence—Metformin—polycystic ovary syndrome	0.000285	0.0208	CcSEcCtD
Lithium—Dyspepsia—Metformin—polycystic ovary syndrome	0.000282	0.0206	CcSEcCtD
Lithium—Decreased appetite—Metformin—polycystic ovary syndrome	0.000279	0.0203	CcSEcCtD
Lithium—Fatigue—Metformin—polycystic ovary syndrome	0.000276	0.0202	CcSEcCtD
Lithium—Feeling abnormal—Metformin—polycystic ovary syndrome	0.000264	0.0193	CcSEcCtD
Lithium—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.000262	0.0191	CcSEcCtD
Lithium—Abdominal pain—Metformin—polycystic ovary syndrome	0.000254	0.0185	CcSEcCtD
Lithium—Asthenia—Metformin—polycystic ovary syndrome	0.00023	0.0168	CcSEcCtD
Lithium—GSK3B—TCF dependent signaling in response to WNT—AKT2—polycystic ovary syndrome	0.00023	0.000343	CbGpPWpGaD
Lithium—GSK3B—Signaling by NGF—IRS2—polycystic ovary syndrome	0.000229	0.000342	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—NPB—polycystic ovary syndrome	0.000228	0.00034	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—ADRA1B—polycystic ovary syndrome	0.000228	0.000339	CbGpPWpGaD
Lithium—GSK3B—Glucocorticoid receptor regulatory network—IL6—polycystic ovary syndrome	0.000227	0.000339	CbGpPWpGaD
Lithium—GSK3A—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	0.000226	0.000337	CbGpPWpGaD
Lithium—GSK3B—Focal Adhesion—BCL2—polycystic ovary syndrome	0.000224	0.000334	CbGpPWpGaD
Lithium—GSK3A—Immune System—FGF18—polycystic ovary syndrome	0.000223	0.000332	CbGpPWpGaD
Lithium—GSK3B—RNF mutants show enhanced WNT signaling and proliferation—AKT2—polycystic ovary syndrome	0.000223	0.000332	CbGpPWpGaD
Lithium—IMPA1—Metabolism—MTHFR—polycystic ovary syndrome	0.000222	0.000331	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—INHBB—polycystic ovary syndrome	0.000222	0.000331	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—TNRC6B—polycystic ovary syndrome	0.000222	0.000331	CbGpPWpGaD
Lithium—GSK3A—Disease—AKR1C1—polycystic ovary syndrome	0.000222	0.000331	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—SLC2A4—polycystic ovary syndrome	0.00022	0.000328	CbGpPWpGaD
Lithium—Diarrhoea—Metformin—polycystic ovary syndrome	0.000219	0.016	CcSEcCtD
Lithium—Dizziness—Metformin—polycystic ovary syndrome	0.000212	0.0155	CcSEcCtD
Lithium—GSK3B—Disease—RPL37A—polycystic ovary syndrome	0.00021	0.000313	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.000207	0.000309	CbGpPWpGaD
Lithium—GSK3B—Signaling by WNT in cancer—AKT2—polycystic ovary syndrome	0.000207	0.000308	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—NRG1—polycystic ovary syndrome	0.000206	0.000308	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	0.000206	0.000308	CbGpPWpGaD
Lithium—GSK3A—Disease—FGF18—polycystic ovary syndrome	0.000206	0.000307	CbGpPWpGaD
Lithium—GSK3A—Disease—RBP4—polycystic ovary syndrome	0.000204	0.000304	CbGpPWpGaD
Lithium—Vomiting—Metformin—polycystic ovary syndrome	0.000204	0.0149	CcSEcCtD
Lithium—GSK3A—Immune System—GAB1—polycystic ovary syndrome	0.000203	0.000303	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—ATF1—polycystic ovary syndrome	0.000203	0.000302	CbGpPWpGaD
Lithium—GSK3B—Immune System—RACGAP1—polycystic ovary syndrome	0.000203	0.000302	CbGpPWpGaD
Lithium—IMPA2—Metabolism—PPARG—polycystic ovary syndrome	0.000202	0.000302	CbGpPWpGaD
Lithium—Rash—Metformin—polycystic ovary syndrome	0.000202	0.0147	CcSEcCtD
Lithium—Dermatitis—Metformin—polycystic ovary syndrome	0.000202	0.0147	CcSEcCtD
Lithium—Headache—Metformin—polycystic ovary syndrome	0.000201	0.0146	CcSEcCtD
Lithium—GSK3B—Signaling by NGF—IRS1—polycystic ovary syndrome	0.0002	0.000298	CbGpPWpGaD
Lithium—IMPA2—Metabolism—POMC—polycystic ovary syndrome	0.000199	0.000297	CbGpPWpGaD
Lithium—GSK3A—Signaling by SCF-KIT—IL6—polycystic ovary syndrome	0.000199	0.000297	CbGpPWpGaD
Lithium—GSK3B—Disease—HMMR—polycystic ovary syndrome	0.000199	0.000297	CbGpPWpGaD
Lithium—IMPA2—Metabolism—INS—polycystic ovary syndrome	0.000198	0.000296	CbGpPWpGaD
Lithium—GSK3A—Adaptive Immune System—NRG1—polycystic ovary syndrome	0.000198	0.000296	CbGpPWpGaD
Lithium—GSK3A—Downstream signaling of activated FGFR—IL6—polycystic ovary syndrome	0.000191	0.000284	CbGpPWpGaD
Lithium—Nausea—Metformin—polycystic ovary syndrome	0.00019	0.0139	CcSEcCtD
Lithium—GSK3B—Signaling Pathways—PTGER3—polycystic ovary syndrome	0.00019	0.000284	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—LHCGR—polycystic ovary syndrome	0.00019	0.000284	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—FSHR—polycystic ovary syndrome	0.000189	0.000281	CbGpPWpGaD
Lithium—GSK3A—Disease—GAB1—polycystic ovary syndrome	0.000188	0.00028	CbGpPWpGaD
Lithium—GSK3A—Signaling by ERBB4—IL6—polycystic ovary syndrome	0.000188	0.00028	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—TAB1—polycystic ovary syndrome	0.000187	0.000279	CbGpPWpGaD
Lithium—GSK3B—Senescence and Autophagy in Cancer—IL6—polycystic ovary syndrome	0.000186	0.000278	CbGpPWpGaD
Lithium—GSK3B—Signaling by NGF—AKT2—polycystic ovary syndrome	0.000185	0.000276	CbGpPWpGaD
Lithium—GSK3A—Immune System—CAMK2D—polycystic ovary syndrome	0.000185	0.000276	CbGpPWpGaD
Lithium—GSK3A—Disease—NAMPT—polycystic ovary syndrome	0.000183	0.000273	CbGpPWpGaD
Lithium—GSK3A—Immune System—TNRC6B—polycystic ovary syndrome	0.000182	0.000271	CbGpPWpGaD
Lithium—IMPA1—Metabolism—PPARG—polycystic ovary syndrome	0.00018	0.000269	CbGpPWpGaD
Lithium—GSK3A—Downstream signal transduction—IL6—polycystic ovary syndrome	0.000179	0.000267	CbGpPWpGaD
Lithium—GSK3A—Signaling by FGFR—IL6—polycystic ovary syndrome	0.000178	0.000266	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—PTAFR—polycystic ovary syndrome	0.000178	0.000265	CbGpPWpGaD
Lithium—IMPA1—Metabolism—POMC—polycystic ovary syndrome	0.000178	0.000265	CbGpPWpGaD
Lithium—GSK3A—Signaling by ERBB2—IL6—polycystic ovary syndrome	0.000178	0.000265	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000177	0.000264	CbGpPWpGaD
Lithium—IMPA1—Metabolism—INS—polycystic ovary syndrome	0.000177	0.000264	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—IRS2—polycystic ovary syndrome	0.000177	0.000264	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—CRP—polycystic ovary syndrome	0.000177	0.000264	CbGpPWpGaD
Lithium—GSK3A—DAP12 signaling—IL6—polycystic ovary syndrome	0.000177	0.000263	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—NCOR1—polycystic ovary syndrome	0.000176	0.000262	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—ADRA1D—polycystic ovary syndrome	0.000173	0.000258	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000172	0.000257	CbGpPWpGaD
Lithium—GSK3A—Disease—AKR1C3—polycystic ovary syndrome	0.000171	0.000255	CbGpPWpGaD
Lithium—GSK3B—Signaling by Wnt—AKT2—polycystic ovary syndrome	0.00017	0.000254	CbGpPWpGaD
Lithium—GSK3A—Adaptive Immune System—IRS2—polycystic ovary syndrome	0.00017	0.000253	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—ADRA1B—polycystic ovary syndrome	0.000168	0.000251	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—FST—polycystic ovary syndrome	0.000168	0.000251	CbGpPWpGaD
Lithium—GSK3A—Disease—TNRC6B—polycystic ovary syndrome	0.000168	0.000251	CbGpPWpGaD
Lithium—GSK3B—Focal Adhesion—VEGFA—polycystic ovary syndrome	0.000168	0.00025	CbGpPWpGaD
Lithium—GSK3A—Fc epsilon receptor (FCERI) signaling—IL6—polycystic ovary syndrome	0.000166	0.000248	CbGpPWpGaD
Lithium—GSK3A—Signaling by FGFR in disease—IL6—polycystic ovary syndrome	0.000166	0.000248	CbGpPWpGaD
Lithium—GSK3A—DAP12 interactions—IL6—polycystic ovary syndrome	0.000166	0.000248	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000166	0.000248	CbGpPWpGaD
Lithium—GSK3A—Signaling by EGFR—IL6—polycystic ovary syndrome	0.000165	0.000246	CbGpPWpGaD
Lithium—GSK3B—Immune System—FGF18—polycystic ovary syndrome	0.000165	0.000246	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—LHB—polycystic ovary syndrome	0.000164	0.000245	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—INHBB—polycystic ovary syndrome	0.000164	0.000244	CbGpPWpGaD
Lithium—GSK3B—Disease—AKR1C1—polycystic ovary syndrome	0.000164	0.000244	CbGpPWpGaD
Lithium—GSK3A—Signaling by EGFR in Cancer—IL6—polycystic ovary syndrome	0.000163	0.000243	CbGpPWpGaD
Lithium—GSK3A—Signaling by PDGF—IL6—polycystic ovary syndrome	0.000163	0.000242	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.00016	0.000239	CbGpPWpGaD
Lithium—GSK3A—Immune System—ATF1—polycystic ovary syndrome	0.00016	0.000238	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000155	0.000232	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—IRS1—polycystic ovary syndrome	0.000154	0.00023	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—SCT—polycystic ovary syndrome	0.000154	0.000229	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.000153	0.000228	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—NRG1—polycystic ovary syndrome	0.000152	0.000227	CbGpPWpGaD
Lithium—GSK3B—Disease—FGF18—polycystic ovary syndrome	0.000152	0.000227	CbGpPWpGaD
Lithium—GSK3A—Metabolism of proteins—LEP—polycystic ovary syndrome	0.000151	0.000225	CbGpPWpGaD
Lithium—GSK3B—Disease—RBP4—polycystic ovary syndrome	0.000151	0.000225	CbGpPWpGaD
Lithium—GSK3B—Immune System—GAB1—polycystic ovary syndrome	0.00015	0.000224	CbGpPWpGaD
Lithium—GSK3A—Adaptive Immune System—IRS1—polycystic ovary syndrome	0.000148	0.000221	CbGpPWpGaD
Lithium—GSK3A—Immune System—TAB1—polycystic ovary syndrome	0.000147	0.00022	CbGpPWpGaD
Lithium—GSK3B—Signaling by SCF-KIT—IL6—polycystic ovary syndrome	0.000147	0.00022	CbGpPWpGaD
Lithium—GSK3A—NGF signalling via TRKA from the plasma membrane—IL6—polycystic ovary syndrome	0.000147	0.00022	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000147	0.000219	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—NRG1—polycystic ovary syndrome	0.000146	0.000218	CbGpPWpGaD
Lithium—GSK3A—Immune System—PRL—polycystic ovary syndrome	0.000146	0.000218	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—LEP—polycystic ovary syndrome	0.000145	0.000216	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000144	0.000215	CbGpPWpGaD
Lithium—GSK3A—Disease—TCF7L2—polycystic ovary syndrome	0.000144	0.000215	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000143	0.000213	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—AKT2—polycystic ovary syndrome	0.000143	0.000213	CbGpPWpGaD
Lithium—GSK3A—Disease—SLC2A4—polycystic ovary syndrome	0.000141	0.000211	CbGpPWpGaD
Lithium—GSK3B—Downstream signaling of activated FGFR—IL6—polycystic ovary syndrome	0.000141	0.00021	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—FSHR—polycystic ovary syndrome	0.000139	0.000208	CbGpPWpGaD
Lithium—GSK3B—Disease—GAB1—polycystic ovary syndrome	0.000139	0.000207	CbGpPWpGaD
Lithium—GSK3B—Signaling by ERBB4—IL6—polycystic ovary syndrome	0.000139	0.000207	CbGpPWpGaD
Lithium—GSK3A—Adaptive Immune System—AKT2—polycystic ovary syndrome	0.000137	0.000205	CbGpPWpGaD
Lithium—GSK3B—Immune System—CAMK2D—polycystic ovary syndrome	0.000137	0.000204	CbGpPWpGaD
Lithium—GSK3B—Disease—NAMPT—polycystic ovary syndrome	0.000135	0.000202	CbGpPWpGaD
Lithium—GSK3A—Disease—PRL—polycystic ovary syndrome	0.000135	0.000201	CbGpPWpGaD
Lithium—GSK3B—Immune System—TNRC6B—polycystic ovary syndrome	0.000134	0.000201	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000133	0.000199	CbGpPWpGaD
Lithium—GSK3B—Downstream signal transduction—IL6—polycystic ovary syndrome	0.000132	0.000198	CbGpPWpGaD
Lithium—GSK3B—Signaling by FGFR—IL6—polycystic ovary syndrome	0.000132	0.000197	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000132	0.000196	CbGpPWpGaD
Lithium—GSK3B—Signaling by ERBB2—IL6—polycystic ovary syndrome	0.000131	0.000196	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000131	0.000195	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—IRS2—polycystic ovary syndrome	0.000131	0.000195	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—CRP—polycystic ovary syndrome	0.000131	0.000195	CbGpPWpGaD
Lithium—GSK3B—DAP12 signaling—IL6—polycystic ovary syndrome	0.000131	0.000195	CbGpPWpGaD
Lithium—GSK3A—Metabolism of proteins—POMC—polycystic ovary syndrome	0.00013	0.000194	CbGpPWpGaD
Lithium—GSK3A—Metabolism of proteins—INS—polycystic ovary syndrome	0.000129	0.000193	CbGpPWpGaD
Lithium—GSK3B—Cellular responses to stress—VEGFA—polycystic ovary syndrome	0.000129	0.000192	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000127	0.00019	CbGpPWpGaD
Lithium—GSK3B—Disease—AKR1C3—polycystic ovary syndrome	0.000126	0.000188	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—PPARG—polycystic ovary syndrome	0.000126	0.000188	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—INSR—polycystic ovary syndrome	0.000126	0.000188	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—IRS2—polycystic ovary syndrome	0.000125	0.000187	CbGpPWpGaD
Lithium—GSK3A—Metabolism of proteins—IGF1—polycystic ovary syndrome	0.000125	0.000186	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—BCL2—polycystic ovary syndrome	0.000125	0.000186	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—FST—polycystic ovary syndrome	0.000124	0.000185	CbGpPWpGaD
Lithium—GSK3B—Disease—TNRC6B—polycystic ovary syndrome	0.000124	0.000185	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—INS—polycystic ovary syndrome	0.000124	0.000184	CbGpPWpGaD
Lithium—GSK3A—Immune System—IL18—polycystic ovary syndrome	0.000123	0.000183	CbGpPWpGaD
Lithium—GSK3B—Fc epsilon receptor (FCERI) signaling—IL6—polycystic ovary syndrome	0.000123	0.000183	CbGpPWpGaD
Lithium—GSK3B—DAP12 interactions—IL6—polycystic ovary syndrome	0.000123	0.000183	CbGpPWpGaD
Lithium—GSK3B—Signaling by FGFR in disease—IL6—polycystic ovary syndrome	0.000123	0.000183	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000123	0.000183	CbGpPWpGaD
Lithium—GSK3B—Signaling by EGFR—IL6—polycystic ovary syndrome	0.000122	0.000182	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—LHB—polycystic ovary syndrome	0.000121	0.000181	CbGpPWpGaD
Lithium—GSK3B—Signaling by EGFR in Cancer—IL6—polycystic ovary syndrome	0.000121	0.00018	CbGpPWpGaD
Lithium—GSK3A—Immune System—NRG1—polycystic ovary syndrome	0.00012	0.000179	CbGpPWpGaD
Lithium—GSK3B—Signaling by PDGF—IL6—polycystic ovary syndrome	0.00012	0.000179	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.00012	0.000178	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—AKT2—polycystic ovary syndrome	0.00012	0.000178	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000118	0.000177	CbGpPWpGaD
Lithium—GSK3B—Immune System—ATF1—polycystic ovary syndrome	0.000118	0.000176	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000118	0.000175	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—PGR—polycystic ovary syndrome	0.000116	0.000174	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000115	0.000171	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—IRS1—polycystic ovary syndrome	0.000114	0.00017	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—SCT—polycystic ovary syndrome	0.000114	0.000169	CbGpPWpGaD
Lithium—GSK3A—Signaling by NGF—IL6—polycystic ovary syndrome	0.000113	0.000169	CbGpPWpGaD
Lithium—GSK3A—Disease—NCOR1—polycystic ovary syndrome	0.000113	0.000169	CbGpPWpGaD
Lithium—GSK3A—Disease—NRG1—polycystic ovary syndrome	0.000111	0.000165	CbGpPWpGaD
Lithium—GSK3B—Circadian rythm related genes—IL6—polycystic ovary syndrome	0.000111	0.000165	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—IRS1—polycystic ovary syndrome	0.000109	0.000163	CbGpPWpGaD
Lithium—GSK3B—Axon guidance—VEGFA—polycystic ovary syndrome	0.000109	0.000163	CbGpPWpGaD
Lithium—GSK3B—Immune System—TAB1—polycystic ovary syndrome	0.000109	0.000162	CbGpPWpGaD
Lithium—GSK3B—NGF signalling via TRKA from the plasma membrane—IL6—polycystic ovary syndrome	0.000109	0.000162	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000108	0.000162	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000108	0.000161	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000108	0.000161	CbGpPWpGaD
Lithium—GSK3B—Immune System—PRL—polycystic ovary syndrome	0.000108	0.000161	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000106	0.000159	CbGpPWpGaD
Lithium—GSK3B—Disease—TCF7L2—polycystic ovary syndrome	0.000106	0.000159	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000106	0.000157	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—AKT2—polycystic ovary syndrome	0.000106	0.000157	CbGpPWpGaD
Lithium—GSK3B—Disease—SLC2A4—polycystic ovary syndrome	0.000105	0.000156	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000103	0.000154	CbGpPWpGaD
Lithium—GSK3A—Immune System—IRS2—polycystic ovary syndrome	0.000103	0.000154	CbGpPWpGaD
Lithium—GSK3A—Immune System—CRP—polycystic ovary syndrome	0.000103	0.000154	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—AKT2—polycystic ovary syndrome	0.000101	0.000151	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000101	0.00015	CbGpPWpGaD
Lithium—GSK3A—Disease—MTHFR—polycystic ovary syndrome	9.99e-05	0.000149	CbGpPWpGaD
Lithium—GSK3B—Disease—PRL—polycystic ovary syndrome	9.97e-05	0.000149	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—YAP1—polycystic ovary syndrome	9.86e-05	0.000147	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—GAB1—polycystic ovary syndrome	9.72e-05	0.000145	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—NGFR—polycystic ovary syndrome	9.53e-05	0.000142	CbGpPWpGaD
Lithium—GSK3A—Disease—IRS2—polycystic ovary syndrome	9.51e-05	0.000142	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—PRL—polycystic ovary syndrome	9.45e-05	0.000141	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—INSR—polycystic ovary syndrome	9.3e-05	0.000139	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—BCL2—polycystic ovary syndrome	9.22e-05	0.000137	CbGpPWpGaD
Lithium—GSK3B—Immune System—IL18—polycystic ovary syndrome	9.08e-05	0.000135	CbGpPWpGaD
Lithium—GSK3A—Immune System—IRS1—polycystic ovary syndrome	8.99e-05	0.000134	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—ADRB2—polycystic ovary syndrome	8.96e-05	0.000134	CbGpPWpGaD
Lithium—GSK3B—Cellular responses to stress—IL6—polycystic ovary syndrome	8.92e-05	0.000133	CbGpPWpGaD
Lithium—GSK3B—Immune System—NRG1—polycystic ovary syndrome	8.88e-05	0.000132	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—AKR1C3—polycystic ovary syndrome	8.83e-05	0.000132	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—TNRC6B—polycystic ovary syndrome	8.69e-05	0.00013	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—PGR—polycystic ovary syndrome	8.61e-05	0.000128	CbGpPWpGaD
Lithium—GSK3B—Signaling by NGF—IL6—polycystic ovary syndrome	8.37e-05	0.000125	CbGpPWpGaD
Lithium—GSK3B—Disease—NCOR1—polycystic ovary syndrome	8.35e-05	0.000125	CbGpPWpGaD
Lithium—GSK3A—Immune System—AKT2—polycystic ovary syndrome	8.32e-05	0.000124	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—GNAS—polycystic ovary syndrome	8.31e-05	0.000124	CbGpPWpGaD
Lithium—GSK3A—Disease—IRS1—polycystic ovary syndrome	8.3e-05	0.000124	CbGpPWpGaD
Lithium—GSK3B—Disease—NRG1—polycystic ovary syndrome	8.2e-05	0.000122	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—GHRL—polycystic ovary syndrome	8e-05	0.000119	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—PLAT—polycystic ovary syndrome	8e-05	0.000119	CbGpPWpGaD
Lithium—GSK3A—Disease—INS—polycystic ovary syndrome	7.95e-05	0.000119	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—NCOR1—polycystic ovary syndrome	7.92e-05	0.000118	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—VEGFA—polycystic ovary syndrome	7.81e-05	0.000116	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—NRG1—polycystic ovary syndrome	7.77e-05	0.000116	CbGpPWpGaD
Lithium—GSK3A—Disease—AKT2—polycystic ovary syndrome	7.68e-05	0.000115	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—ATF1—polycystic ovary syndrome	7.63e-05	0.000114	CbGpPWpGaD
Lithium—GSK3B—Immune System—IRS2—polycystic ovary syndrome	7.61e-05	0.000113	CbGpPWpGaD
Lithium—GSK3B—Immune System—CRP—polycystic ovary syndrome	7.61e-05	0.000113	CbGpPWpGaD
Lithium—GSK3B—Axon guidance—IL6—polycystic ovary syndrome	7.57e-05	0.000113	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—TCF7L2—polycystic ovary syndrome	7.44e-05	0.000111	CbGpPWpGaD
Lithium—GSK3B—Disease—MTHFR—polycystic ovary syndrome	7.38e-05	0.00011	CbGpPWpGaD
Lithium—GSK3A—Disease—SERPINE1—polycystic ovary syndrome	7.3e-05	0.000109	CbGpPWpGaD
Lithium—GSK3A—Immune System—BCL2—polycystic ovary syndrome	7.27e-05	0.000108	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—NGFR—polycystic ovary syndrome	7.04e-05	0.000105	CbGpPWpGaD
Lithium—GSK3B—Disease—IRS2—polycystic ovary syndrome	7.02e-05	0.000105	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—PRL—polycystic ovary syndrome	6.98e-05	0.000104	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—IRS2—polycystic ovary syndrome	6.66e-05	9.93e-05	CbGpPWpGaD
Lithium—GSK3B—Immune System—IRS1—polycystic ovary syndrome	6.64e-05	9.9e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—ADRB2—polycystic ovary syndrome	6.62e-05	9.88e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—LEP—polycystic ovary syndrome	6.51e-05	9.71e-05	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—IL6—polycystic ovary syndrome	6.46e-05	9.63e-05	CbGpPWpGaD
Lithium—GSK3B—Immune System—AKT2—polycystic ovary syndrome	6.15e-05	9.17e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—GNAS—polycystic ovary syndrome	6.14e-05	9.16e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—IRS1—polycystic ovary syndrome	6.13e-05	9.14e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—INS—polycystic ovary syndrome	5.87e-05	8.76e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—NCOR1—polycystic ovary syndrome	5.85e-05	8.72e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—IRS1—polycystic ovary syndrome	5.81e-05	8.67e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—NRG1—polycystic ovary syndrome	5.74e-05	8.56e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—AKT2—polycystic ovary syndrome	5.68e-05	8.46e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—POMC—polycystic ovary syndrome	5.6e-05	8.35e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—INS—polycystic ovary syndrome	5.56e-05	8.3e-05	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—IL6—polycystic ovary syndrome	5.4e-05	8.06e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—SERPINE1—polycystic ovary syndrome	5.39e-05	8.04e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—IGF1—polycystic ovary syndrome	5.38e-05	8.03e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—AKT2—polycystic ovary syndrome	5.38e-05	8.02e-05	CbGpPWpGaD
Lithium—GSK3B—Immune System—BCL2—polycystic ovary syndrome	5.37e-05	8.01e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—SERPINE1—polycystic ovary syndrome	5.11e-05	7.62e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—IRS2—polycystic ovary syndrome	4.92e-05	7.34e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—LEP—polycystic ovary syndrome	4.81e-05	7.18e-05	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—IL6—polycystic ovary syndrome	4.77e-05	7.12e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—IRS1—polycystic ovary syndrome	4.29e-05	6.4e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—POMC—polycystic ovary syndrome	4.14e-05	6.17e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—INS—polycystic ovary syndrome	4.11e-05	6.13e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—IGF1—polycystic ovary syndrome	3.98e-05	5.93e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—AKT2—polycystic ovary syndrome	3.97e-05	5.93e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—SERPINE1—polycystic ovary syndrome	3.78e-05	5.63e-05	CbGpPWpGaD
Lithium—GSK3A—Immune System—IL6—polycystic ovary syndrome	3.76e-05	5.61e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—VEGFA—polycystic ovary syndrome	3.52e-05	5.24e-05	CbGpPWpGaD
Lithium—GSK3A—Disease—IL6—polycystic ovary syndrome	3.47e-05	5.18e-05	CbGpPWpGaD
Lithium—GSK3B—Immune System—IL6—polycystic ovary syndrome	2.78e-05	4.14e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—VEGFA—polycystic ovary syndrome	2.6e-05	3.87e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—IL6—polycystic ovary syndrome	2.57e-05	3.83e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—IL6—polycystic ovary syndrome	2.43e-05	3.63e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—IL6—polycystic ovary syndrome	1.8e-05	2.68e-05	CbGpPWpGaD
